The proinflammatory cytokine response to coagulation and endotoxin in whole blood

Blood

Volumn 87, Issue 12, 1996, Pages 5051-5060

  Johnson, Kirk ^a   Aarden, Lucien ^b   Choi, Yoon ^b   De Groot, Els ^b   Creasey, Abla ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; APROTININ; CYTOKINE; ENDOTOXIN; HIRUDIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING; BLOOD CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; MOLECULAR INTERACTION; MONONUCLEAR CELL; PRIORITY JOURNAL; SEPSIS;

EID: 0029996796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5051.bloodjournal87125051     Document Type: Article

References (46)

1. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Harir RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470, 1986
2. Okusawa S, Gelfand JA, Ikejima T, Conolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cycloxygenase inhibition. J Clin Invest 81:1162, 1988
3. Waage A, Espevik T: Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 16:1987, 1988
4. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165, 1989
5. van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520, 1990
6. van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowy SF, Moldawer LL: IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146:347, 1991
7. Creasey AA, Stevens P, Kenney J, Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr: Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal escherichia coli. Circ Shock 33:84, 1991
8. Taylor FB Jr: Baboon model of E. coli sepsis: Summary of staging, mechanism, and diagnostic markers. Mol Aspects Inflammation 42:277, 1991
9. Boermeester MA, van Leeuwen PAM, Coyle SM, Wolkink GJ, Hack CE, Lowry, SF: Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch Surg 130:739, 1995
10. Furie B, Furie BC: The molecular basis of blood coagulation. Cell 53:505, 1988
11. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S: Surface-dependent reactions of the vitaminK-dependent enzyme complexes. Blood 76:1, 1990
12. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30:10363, 1991
13. Esmon CT: Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 9:1, 1993
14. Maynard JR, Heckman CA, Pitlick FA, Nemerson Y: Association of tissue factor activity with the surface of cultured cells. J Clin Invest 55:814, 1975
15. Lerner RG, Goldstein R, Cummings G: Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med 138:145 1971
16. Bevilacqua MP, Pober JS, Majean GR: Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular cells. J Exp Med 160:618, 1984
17. Bevilacqua MP, Pober JS, Majean GR: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83:4533, 1986
18. Gregory SA, Morrissey JM, Edgington TS: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752, 1989
19. Mason JW, Colman RW: The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. Thromb Diath Haemorrh 26:325, 1971
20. Hack CE, Nuijens JH, Van Schijndel RJMS, Abbink JJ, Eerenberg AJM, Thijs LG: A model for the interplay of inflammatory mediators in sepsis - A study in 48 patients. Intensive Care Med 16:S187, 1990 (suppl 3)
21. Marder VJ, Martin SE, Francis CW, Colman RW: Consumptive thrombohemorrhagic disorders, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 2). Philadelphia, PA, Lippincott, 1987, p 975
22. Bone RC: Modulators of coagulation: A critical appraisal of their role in sepsis. Arch Intern Med 152:1381, 1992
23. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117, 1995
24. Stringer KA, Lindenfeld JA: Hirudins: Antithrombin anticoagulants. Ann Pharmacother 26:1535, 1992
25. Sanders NL, Bajaj SP, Zivelin A, Rapaport SI: Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood 66:204, 1985
26. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard TJ, Miletich JP: The lipoprotein-associated coagulation inhibitor that inhibits factor VII-tissue factor complex also inhibits Xa: Insight into its possible mechanism of action. Blood 71:335, 1988
27. Wun T-C, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr: Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 263:6001, 1988
28. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338:519, 1989
29. Rapaport SI: The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb Haemost 66:1, 1991
30. Broze GJ Jr: The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 29:159, 1992
31. Broze GJ Jr, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29:7539, 1990
32. Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50:803, 1988
33. Valentin S, Ostergaard P, Kistensen H, Nordfang O: Synergism between full length TFPI and heparin: Evidence for TFPI as an important factor for the antithrombotic activity of heparin. Blood Coagul Fibrinolysis 3:221, 1992
34. Creasey AA, Chang ACK, Feigen L, Wun T-C, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850, 1993
35. Carr C, Bild GS, Chang ACK, Peer GT, Palmier MO, Frazier RB, Gustafson ME, Wun T-C, Creasey AA, Hinshaw LB, Taylor FB Jr, Galluppi GR: Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock 44:126, 1995
36. Girard TJ, Carr C, Heeren R, Gustafson M, Chang ACK, Taylor FB Jr, Hinshaw LB, Mast AE, Broze GJ Jr, Stewart JA, Schwartz BD, Westlin WF, Galluppi GR: Comparing full-length and truncated tissue factor pathway inhibitor in a primate sepsis model. Blood (submitted)
37. van Deventer SJ, Hart M, van der Poll T, Hack CE, Aarden LA: Endotoxin- and TNFα-induced IL8 release in humans. J Infect Dis 167:461, 1993
38. Helle M, Boeije L, De Groot ER, de Vos A, Aarden LA: Sensitive ELISA for detection of IL6 in biological fluids: Synovial fluids and sera. J Immunol Methods 138:47, 1991
39. Wesselschmidt R, Likert KM, Girard TJ, Wun T-C, Broze GJ Jr: Tissue factor pathway inhibitor: The carboxy terminus is required for optimal inhibition of factor Xa. Blood 79:2004, 1992
40. Bar-Shavit R, Kahn A, Wilner GD, Fenton JW: Monocyte chemotaxis: Stimulation by specific exosite region in thrombin. Science 220:728, 1983
41. Jones A, Geczy CL: Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71:236, 1990
42. Naldini A, Carney DH, Bocci V, Kumpel KD, Asuncion M, Soares LE, Klimpel GR: Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 147:367, 1993
43. DeGroote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P: Direct stimulation of cytokines (IL-1β, TNFα, IL-6, IL-2, IFN-γ, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239, 1992
44. Deforge LE, Kenney JS, Jones ML, Warren JS, Remick DG: Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. J Immunol 148:2133, 1992
45. Altieri D: Proteases and protease receptors in modulation of leukocyte effector functions. J Leukoc Biol 58:120, 1995
46. Hack CE, De Groot ER, Felt-Bersma JF, Nuijens JH, Van Schijndel RJMS, Eerenberg-Belmer AJM, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704, 1989